Description

Dr. Ashish Shetty addresses the controversial topic of spinal cord stimulator (SCS) screening trials. He highlights the challenges associated with such trials, and the risks involved in not performing them. Dr. Shetty also speaks about the absence of a consensus among surgeons, pain management specialists, and in the literature. He advises that screening trials are necessary for patient selection, but proposes simplifying and reducing the cost of these trials, to aid physicians and surgeons.